Nuclear Imaging
Molecular imaging, also called nuclear imaging, includes positron emission computed tomography (PET) and single photon emission computed tomography (SPECT) imaging. This section includes radiopharmaceuticals and tracers, PET-CT, SPECT-CT, and PET-MRI.
Hepatic 18F-FDG, 18F-FAC, and 18F-DFA accumulation are affected in a mouse model of autoimmune hepatitis. (A) Histochemical and immunohistochemical analyses of liver sections from vehicle- and ConA-treated mice. Scale bars represent 50 microns. Transverse PET/CT images (B) and quantification (C) of vehicle- and ConA-treated mice injected with 18F-FDG, 18F-FAC, and 18FDFA. Livers are outlined in a white dotted line. Quantification represents radiotracer accumulation in the liver normalized to a background organ. Image courtesy of Salas J.R., Chen B.Y., Wong A., et al.
News | PET Imaging | October 24, 2018
October 24, 2018 — While liver biopsies are powerful and reliable, they are also invasive, painful, limited and subject...
Videos | Interventional Radiology | October 19, 2018
Each digital photon counter in the Vereos PET/CT detector contains thousands of solid-state sensors that digitally count individual photons.
Sponsored Content | Blog | PET-CT | October 17, 2018
Analog is approximate. Digital is specific. Therein lies the fundamental difference between digital PET and its analog...
Sponsored Content
Staging F18FDG PET/CT images of adenocarcinoma in the RUL (right upper lobe) of the lung illustrates the value of Vereos. The primary lesion in the right upper lobe appears in the upper row (PET image is left, CT image is right). A 3 mm synchronous primary or metastatic lesion in the RUL is apparent in the lower row. The precision afforded by Vereos' images provided the basis for the patient to undergo RUL lobectomy instead of thermal ablation of the primary lesion. (Images courtesy of Dr. Jay Kikut and UVMC)
Blog | PET-CT | October 25, 2018
Efficiency and effectiveness are inseparable in clinical medicine. Digital PET addresses them both.
News | Radiopharmaceuticals and Tracers | October 12, 2018
October 12, 2018 — The Council on Radionuclides and Radiopharmaceuticals Inc. (CORAR) — the voice of the radionuclide...
News | PET-MRI | October 10, 2018
October 10, 2018 — The Center for Quantitative Cancer Imaging at Huntsman Cancer Institute (HCI) at the University of...
Digital PET/CT, achieved using Vereos from Philips Healthcare, can spot even a small lesion (arrow). Image courtesy of Brian Gordon, M.D.
Sponsored Content | Blog | PET-CT | October 08, 2018
PET/CT can be indispensible as a diagnostic and prognostic tool; in the assessment of patient response to therapy and...
News | Nuclear Imaging | September 27, 2018
September 27, 2018 — Advancements in healthcare technology, particularly in the surgery category, have led to an...
Technology | PET-CT | September 26, 2018
September 26, 2018 — Bruker recently announced the introduction of the new preclinical...
News | Women's Health | September 11, 2018
Shimadzu Corp. has entered the medical near-infrared camera market with the release of the Lightvision near-infrared...
The Siemens Biograph Vision PET-CT system was released in mid-2018.
Feature | Nuclear Imaging | September 07, 2018 | By Dave Fornell
Nuclear imaging technology for both single...
News | PET Imaging | September 05, 2018
September 5, 2018 — Eli Lilly and Co. and Avid Radiopharmaceuticals Inc. announced a Phase 3 study of...
News | SPECT Imaging | August 27, 2018
August 27, 2018 — In the largest known brain imaging study, scientists from five institutions evaluated 62,454 brain...
Researchers are using the tracer, which is injected into a patient, then seen with a PET scan, to see if it is possible to diagnose chronic traumatic encephalopathy in living patients. In this image, warmer colors indicate a higher concentration of the tracer, which binds to abnormal proteins in the brain. Credit UCLA Health.
News | PET Imaging | August 24, 2018
August 24, 2018 — In a small study of...
News | PET Imaging | July 17, 2018
July 17, 2018 — A new way to examine stress and inflammation in the heart will help Parkinson’s researchers test new...
Technology | Nuclear Imaging | July 16, 2018
July 16, 2018 — At the 2018 Annual Meeting of the Society of Nuclear Medicine and Molecular Imaging (SNMMI), June 23-26...
IMAGE OF THE YEAR: PSMA PET before and after lutetium-177 PSMA617 theranostics in 8 patients with metastatic prostate cancer who exhausted standard therapeutic options.
68Ga-PSMA11 PET maximum intensity projection (MIP) images at baseline and 3 months after 177Lu-PSMA617 in 8 patients with PSA decline ≥ 98 percent in a prospective phase II study. Any disease with SUV over 3 is in red. Credit: Michael Hofman, John Violet, Shahneen Sandhu, Justin Ferdinandus, Amir Iravani, Grace Kong, Aravind Ravi Kumar, Tim Akhurst, Sue Ping Thang, Price Jackson, Mark Scalzo, Scott Williams and Rodney Hicks, Peter MacCallum Cancer Centre, Melbourne, Australia.
News | PET Imaging | June 29, 2018
June 29, 2018 — In the battle against metastatic castrate-resistant...
Technology | PET Imaging | June 28, 2018
June 28, 2018 — At the 2018 Society of Nuclear Medicine and Molecular Imaging (SNMMI) annual meeting, June 23-26, in...
